Shanghai Ninth Hospital Plastic Surgery: Reconstruction and Expert Teams

Why this department is discussed in reconstruction rather than cosmetic surgery

Shanghai Ninth People's Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, has a plastic and reconstructive surgery department whose documented history is built around repairing tissue damaged by burns, trauma and congenital conditions. A 2017 university feature describes the department's development of microsurgical reconstruction, craniofacial surgery, burn-plastic surgery, lymphedema and vascular-anomaly work, and records national key-discipline recognition in 1985 together with a health-authority key-specialty designation.

For an overseas reader, identifying the purpose of the consultation is important. A question about function after a burn, an existing tissue defect or a congenital abnormality differs from an enquiry about elective appearance surgery. The hospital’s reconstructive record offers a useful way to frame those questions without treating the entire specialty as one operation.

The specialty placed first in the historical 2023 national specialty reputation list. That department-level reference does not rank individual surgeons or its separate subspecialties.

Plastic and reconstructive surgery in China

Documented subspecialty directions: burns, craniofacial work, microsurgery and difficult wounds

The department’s historical account names microsurgical reconstruction, craniofacial surgery, burn-plastic surgery, lymphedema and vascular-anomaly work. The value of this breadth is not that every patient needs several teams. It is that the anatomical problem, the previous treatment and the intended reconstruction can point toward different kinds of expertise.

The 2026 account of Wang Danru’s teaching describes reconstructive care in terms of burn/trauma repair, difficult wounds and congenital abnormalities. For a patient, it is useful to explain both the visible defect and the functional problem: what has changed, what previous care aimed to do and which difficulties remain. That frames an assessment more clearly than a request for a generic cosmetic result.

Tissue prefabrication is another documented research and surgical direction associated with complex facial reconstruction. Rather than assuming it is the preferred answer, patients can ask what the proposed plan is intended to rebuild and why that approach is being considered. Previous procedures and available tissue are matters for individual surgical assessment, not choices an article can make.

Li Qingfeng, Zhang Disheng and the leadership record

The December 2025 Shanghai Jiao Tong University feature identifies Li Qingfeng as hospital vice president and plastic/reconstructive department director, a national key-discipline academic leader and a National Distinguished Young Scholar fund recipient. His documented focus is traumatic tissue repair and regeneration.

Zhang Disheng founded the department. The historical record connects its development with reconstructive surgery rather than limiting the institution’s identity to elective cosmetic procedures. A separate October 2026 report dates his forearm free-flap genital-reconstruction technique to 1984.

Wang Danru is identified in an April 2026 medical-school report as a reconstructive chief physician, doctoral supervisor and hospital deputy party secretary. Her clinical/teaching discussion focuses on tissue defects, function and wound repair. This is a different role from Li Qingfeng’s department-director post.

A hospital-supplied October 2026 report documents a genital-reconstruction group including senior contributor Cheng Kaixiang, deputy chief physician Cheng Chen and chief physician Liu Yang. It illustrates a specific microsurgical direction for complex congenital or acquired defects. The named team should not be substituted for the appropriate group for an unrelated wound, burn or facial reconstruction.

Research directions and what they mean for a patient conversation

The December 2025 university feature describes autologous facial tissue prefabrication and mixed-reality/artificial-intelligence navigation for flap harvesting, including work dated to 2020. These engineering directions concern the planning and transfer of tissue; the account does not establish a standard navigated procedure for every patient.

The severe head/facial burn-repair project described by the medical school studied tissue prefabrication, vascularization, donor-recipient tissue matching and functional reconstruction. Its output included a guideline and monograph as well as technical development. This is a specific body of reconstructive work, not evidence that any tissue defect can be regenerated.

For a patient, the practical value of this record is the questions it prompts. Does the proposed plan involve prefabricated tissue, a free flap or a staged approach? What are the alternatives, including simpler reconstruction? What does the surgeon expect in terms of function as well as appearance? What are the risks of flap failure, donor-site problems and further surgery? These are clinical questions for the treating team, and no published award answers them for an individual case.

A discussion of regenerative research should distinguish a proposed clinical operation from laboratory or experimental work. The questions are what is actually being offered, what evidence supports it for the problem under review and what alternatives exist. Publicity about an innovation alone cannot establish that an experimental option is available or suitable.

Honors and how to read them without overreach

National key-discipline recognition is dated to 1985 in the department’s historical account. The Li Qingfeng-led severe head/facial burn-repair project received the 2016 National Science and Technology Progress Second Prize; the medical-school announcement was published in January 2017. The award year and announcement year should not be confused.

The historical university feature also identifies Li as a recipient of the university’s inaugural science-and-technology achievement first prize. That institutional recognition is separate from the national project award. His funding and academic-leadership recognition in the December 2025 feature likewise describe different parts of an academic record.

These distinctions help a reader evaluate a team without turning an impressive list into an outcome promise. A hospital specialty’s recognition, a project prize and an individual researcher’s honor do not answer the same question. For care planning, each needs to be connected to the actual reconstructive problem and the team that would assess it.

Practical decisions for an overseas reconstructive patient

The first decision is whether the problem is reconstructive at all. A burn scar that restricts movement, a wound that has not healed, a facial deformity present since birth or a defect after tumour removal raises functional and tissue questions that differ from an elective appearance procedure. Describing the problem in those terms helps the hospital route the enquiry to the right team.

For a focused enquiry, ask whether photographs of the defect, previous operative notes, relevant imaging or pathology and a short treatment timeline would help the team assess the request. The appropriate material depends on the problem; this is a question about existing records, not a prescription to obtain new investigations. Sensitive photographs should be shared through an agreed private clinical process.

Before committing to travel, ask what the proposed assessment is intended to decide: the scope of reconstruction, whether more than one stage is being considered, alternatives and follow-up responsibilities. Which uncertainties can be addressed from records and which require an examination? A written explanation of those boundaries is more useful than borrowing an operating or recovery timetable from another patient’s story.

Separately clarify who would review the case, what language support would be needed and which arrangements remain provisional. A named academic’s biography is not an appointment confirmation. Nor does an initial discussion establish admission or final surgical eligibility. Keep clinical selection and practical planning linked, while leaving the clinical decision to the receiving team.

How ChinaSpecialistCare can support this specific enquiry

ChinaSpecialistCare offers independent help organising a reconstructive case summary, relevant records and coordination with a suitable hospital team. We do not own or officially represent Shanghai Ninth People’s Hospital. Acceptance, the surgeon involved and the clinical plan remain subject to hospital assessment; no individual result or named appointment is guaranteed.